Guangzhou Wondfo Biotech Co.,Ltd (300482.SZ)

CNY 23.75

(-0.88%)

Market Cap (In CNY)

11.35 Billion

Revenue (In CNY)

2.76 Billion

Net Income (In CNY)

487.62 Million

Avg. Volume

5.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.2-31.5
PE
-
EPS
-
Beta Value
0.685
ISIN
CNE100002102
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Zhongxiong Peng
Employee Count
-
Website
https://www.wondfo.com.cn
Ipo Date
2015-06-30
Details
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.